Inspire Medical Systems (NYSE:INSP – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday,Zacks.com reports. Other research analysts also recently issued reports about the stock. Oppenheimer reaffirmed a “market perform” rating on shares of Inspire Medical Systems in […]

Zacks Research upgraded shares of Inspire Medical Systems (NYSE:INSP – Free Report) from a strong sell rating to a hold rating in a research report report published on Monday,Zacks.com reports. Other equities research analysts have also recently issued research reports about the stock. Freedom Capital upgraded shares of Inspire Medical Systems to a “strong-buy” rating […]

Snail (NASDAQ:SNAL – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports. A number of other equities research analysts also recently issued reports on SNAL. Wall Street Zen upgraded shares of Snail to a […]

Badger Meter (NYSE:BMI – Get Free Report) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports. A number of other research firms have also recently commented on BMI. Barclays set a $110.00 price target on Badger Meter and gave the […]

Stepan (NYSE:SCL – Get Free Report) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports. Separately, Weiss Ratings lowered shares of Stepan from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, May […]

Equitable (NYSE:EQH – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports. A number of other equities research analysts have also recently weighed in on EQH. Keefe, Bruyette & Woods raised their price target on Equitable from $51.00 […]

Brazil Potash (NYSEAMERICAN:GRO – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports. Several other equities analysts have also recently issued reports on the company. HC Wainwright began coverage on Brazil Potash in a research report […]